FACEBLOCK  SPF30 SUPER SENSITIVE - titanium dioxide and zinc oxide lotion 
Gordon Laboratories, Inc

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

dermalogica®
super
sensitive
faceblock

active ingredients

Titanium Dioxide (6.7%), Zinc Oxide (9.2%).

other ingredients

Water (Aqua), Cyclopentasiloxane, Dimethicone, Butylene Glycol, Dicaprylyl Ether, Polyglyceryl-3 Polydimethylsiloxyethyl Dimethicone, Dimethicone/Vinyl Dimethicone Crosspolymer, Aluminum Hydroxide, Stearic Acid, Camellia Sinensis Leaf Extract, Lavandula Hybrida Oil, Ascorbyl Tetraisopalmitate, Tocopheryl Acetate, Tocopherol, Dimethicone/PEG-10/15 Crosspolymer, Lauryl PEG-9 Polydimethylsiloxyethyl Dimethicone, Triethoxysilylethyl Polydimethylsiloxyethyl Hexyl Dimethicone, Caprylic/Capric Triglyceride, Sodium DNA, Sodium Hyaluronate, Sodium PCA, Dipotassium Glycyrrhizate, Silica, Carbomer, Sodium Chloride, Sodium Citrate, Linalool, Tetrasodium EDTA, Phenoxyethanol, Methylparaben, Propylparaben.

warnings

For external use only, not to be swallowed.

Avoid contact with eyes. If contact occurs, flush thoroughly with water.

If irritation develops, discontinue use.

Do not use on infants under 6 months old.

PRINCIPAL DISPLAY PANEL - 50 ml Carton

super
sensitive
faceblock

spf 30

NPN# 80005547
AUS L 138151

1.7 FL OZ / 50 ml e

dermalogica®

Principal Display Panel - 50 ml Carton
FACEBLOCK   SPF30 SUPER SENSITIVE
titanium dioxide and zinc oxide lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:21839-111
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide3.35 mL  in 50 mL
Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide4.6 mL  in 50 mL
Inactive Ingredients
Ingredient NameStrength
Water (UNII: 059QF0KO0R)  
Cyclomethicone 5 (UNII: 0THT5PCI0R)  
Dimethicone (UNII: 92RU3N3Y1O)  
Butylene Glycol (UNII: 3XUS85K0RA)  
Dicaprylyl Ether (UNII: 77JZM5516Z)  
Aluminum Hydroxide (UNII: 5QB0T2IUN0)  
Stearic Acid (UNII: 4ELV7Z65AP)  
Green Tea Leaf (UNII: W2ZU1RY8B0)  
Lavandin Oil (UNII: 9RES347CKG)  
Alpha-Tocopherol (UNII: H4N855PNZ1)  
Medium-Chain Triglycerides (UNII: C9H2L21V7U)  
Hyaluronate Sodium (UNII: YSE9PPT4TH)  
Sodium Pyrrolidone Carboxylate (UNII: 469OTG57A2)  
Silicon Dioxide (UNII: ETJ7Z6XBU4)  
Sodium Chloride (UNII: 451W47IQ8X)  
Sodium Citrate (UNII: 1Q73Q2JULR)  
Linalool, Dl- (UNII: D81QY6I88E)  
Edetate Sodium (UNII: MP1J8420LU)  
Phenoxyethanol (UNII: HIE492ZZ3T)  
Methylparaben (UNII: A2I8C7HI9T)  
Propylparaben (UNII: Z8IX2SC1OH)  
Product Characteristics
ColorWHITEScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:21839-111-501 in 1 BOX
150 mL in 1 BOTTLE, PLASTIC
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH NOT FINALpart35211/09/2005
Labeler - Gordon Laboratories, Inc (008328619)

Revised: 3/2011
Document Id: abc25671-26c1-4ed3-a027-8c6e16bb0ec9
Set id: ea7f1b7d-b888-4290-b73b-9fb3c5e590d7
Version: 1
Effective Time: 20110318
 
Gordon Laboratories, Inc